Evidence map›Paper›PMID 27402302›Full record

ArticleHuman pathology2016

Association of epithelial-mesenchymal transition and nuclear cofilin with advanced urothelial cancer.

Patrick J Hensley, Daniel Zetter, Craig M Horbinski, Stephen E Strup, Natasha Kyprianou

Open access · greenAbstract read
In one paragraph

Article in Human pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. [High expression of CFL1 and phospho-CFL1 predicts poor prognosis and promotes migration of colon cancer cellsNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. miR-325-3p Overexpression Inhibits Proliferation and Metastasis of Bladder Cancer Cells by Regulating MT3.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. A Role of Tumor-Released Exosomes in Paracrine Dissemination and Metastasis.International journal of molecular sciences · 2018
    Review
  18. Article
  19. Article
  20. Cofilin-2 Acts as a Marker for Predicting Radiotherapy Response and Is a Potential Therapeutic Target in Nasopharyngeal Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Patrick J HensleyDepartment of Urology, University of Kentucky College of Medicine, Lexington, KY 40536; Department of Pathology, University of Kentucky College of Medicine, Lexington, KY 40536.
Daniel ZetterDepartment of Urology, University of Kentucky College of Medicine, Lexington, KY 40536.
Craig M HorbinskiDepartment of Pathology, University of Kentucky College of Medicine, Lexington, KY 40536; Departments of Pathology and Neurosurgery, Northwestern University, Chicago, IL 60611.
Stephen E StrupDepartment of Urology, University of Kentucky College of Medicine, Lexington, KY 40536.
Natasha KyprianouDepartment of Urology, University of Kentucky College of Medicine, Lexington, KY 40536; Department of Pathology, University of Kentucky College of Medicine, Lexington, KY 40536; Department of Molecular Biochemistry, University of Kentucky College of Medicine, Lexington, KY 40536; Department of Toxicology & Cancer Biology, University of Kentucky College of Medicine, Lexington, KY, 40536. Electronic address: nkypr2@email.uky.edu.
University of Kentucky · USNorthwestern University · US

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI KATHLEEN L. O'CONNOR · 2013 to 2026
$38.3M
NCI NIH HHS P30 CA177558
6 · The paper itself

Abstract

Tumor epithelial cells undergo a morphologic shift through the process of EMT with characteristic loss of cell polarity, conferring invasive and metastatic properties during cancer progression. Signaling by transforming growth factor-β mediates EMT programming and its phenotypic reversal to mesenchymal-epithelial transition. The role of EMT in bladder cancer progression to advanced disease is poorly understood. In this study, we conducted a retrospective analysis of the EMT landscape and actin cytoskeleton remodeling in a series of human bladder cancer specimens. Immunoreactivity for E-cadherin, N-cadherin, and vimentin protein expression was performed toward establishing an EMT signature in human bladder cancer. Serial sections were assessed for the primary regulator of the actin cytoskeleton remodeling and transforming growth factor-β signaling effector, cofilin. Our results demonstrate that EMT induction in clinical bladder cancer specimens is significantly associated with bladder cancer progression to high-grade, invasive disease. Evaluation of expression and cellular localization of the cytoskeleton regulator cofilin revealed a significant association between overexpression of nuclear cofilin with bladder cancer progression. This study is of translational significance in defining the value of EMT signature and cytoskeletal cofilin as potential tumor markers and targetable platforms for the treatment of invasive bladder cancer.

Indexed as

Epithelial-Mesenchymal TransitionActin CytoskeletonAntigens, CDBiomarkers, TumorCadherinsCarcinomaCell NucleusCofilin 1Disease ProgressionHumansImmunohistochemistryNeoplasm GradingRetrospective StudiesRNA, MessengerTumor MicroenvironmentUrinary Bladder NeoplasmsAntigens, CDBiomarkers, TumorCadherinsCDH1 protein, humanCDH2 protein, humanCFL1 protein, humanCofilin 1RNA, MessengerActin cytoskeletonBladder cancerE-cadherinN-cadherinPhenotypic changes

Identifiers

PMID27402302
PMCPMC5629972
OpenAlexW2466993997

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.